Jemimet Extended-Release Tablet 50/1000 mg

Adult dose

The usual adult dose of this medication is taken once daily with the evening meal, with gradual dose increments. For this medication, 50/500mg extended-release tablet or 50/1000mg extended-release tablet is usually 1 tablet once a day. Patients taking 25/500mg extended-release tablet or 25/1000mg extended-release tablet should take 2 tablets simultaneously once a day. Gemigliptin 50mg/metformin 500mg extended-release tablet allows for 1.

This medication can rarely cause a serious condition known as lactic acidosis. Lactic acidosis can pose a life-threatening risk due to excessive accumulation of acidic substances in the blood, so special caution is required during treatment with this medication. Additionally, hypoglycemia may occur when used in conjunction with other diabetes medications, such as insulin or sulfonylureas, so blood sugar levels should be closely monitored. This medication should not be used in specific patients, such as those with moderate to severe renal impairment, patients with heart failure, those who have suffered an acute myocardial infarction, patients with severe liver dysfunction, or women who are pregnant or breastfeeding. Before undergoing tests that use radioiodine contrast agents, this medication should be discontinued at least 48 hours prior, and it should only be resumed after confirming that renal function is normal. If symptoms of acute pancreatitis, such as severe abdominal pain, occur during treatment with this medication, it should be stopped immediately and medical consultation is required. Since blood levels of vitamin B12 may decrease, regular blood tests and appropriate treatment, if necessary, should be performed. Skin reactions such as bullous pemphigoid or severe hypersensitivity may occur; if any skin abnormalities arise, you must inform your doctor immediately. When administering this medication to the elderly, caution must be exercised regarding potential renal impairment, and regular renal function tests should be conducted. In case of overdose, seek medical attention promptly for appropriate treatment, especially if symptoms of lactic acidosis are suspected. This medication may interact with other drugs, so it is essential to inform your healthcare provider about any additional medications being taken. Also, the tablet coating may be excreted in the stool, but this does not affect the medication's efficacy, so there's no need for concern. Generally, excessive alcohol consumption should be avoided while taking this medication, and special caution is needed, particularly in cases of liver or kidney disease. Before undergoing any surgery or procedure, consult with your healthcare provider to determine whether to discontinue this medication.

Serious side effects

• Hives
• severe swelling (edema)
• difficulty breathing
• lactic acidosis
• acute pancreatitis
• bullous pemphigoid
• Stevens-Johnson syndrome
• severe skin reactions
• angina
• acute renal failure

Mild side effects

Joint pain, rhinitis, bacteriuria, upper respiratory infection, increased CPK levels in the blood, increased Amylase levels in the blood, increased Lipase levels, fever, diarrhea, urinary tract infection, hypoglycemia, dizziness, nausea, weakness, myalgia, headache, constipation, hypoglycemia with insulin alone or in combination with metformin, dyspepsia, pharyngitis, increased lipase, chronic gastritis, cough, diabetic nephropathy, gastritis, gingivitis, colon issues.

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius to ensure the medication remains effective for a long time.

Appearance

Brown oblong film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle, 56 tablets (14 tablets/PTP × 4)